Cargando…
High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II – the Total Macular Volume. The First Follow-Up Study over 2 Years
Background: Recent studies investigating the use of optical coherence tomography (OCT) in multiple sclerosis (MS) patients have resulted in wide-ranging and often contradictory outcomes. This is mainly due to the complex etiology and heterogeneity of MS, physiological variations in the retinal nerve...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932446/ https://www.ncbi.nlm.nih.gov/pubmed/24605107 http://dx.doi.org/10.3389/fneur.2014.00020 |
_version_ | 1782304797595009024 |
---|---|
author | Serbecic, Nermin Aboul-Enein, Fahmy Beutelspacher, Sven C. Khan, Adnan Vass, Clemens Kristoferitsch, Wolfgang Reitner, Andreas Schmidt-Erfurth, Ursula |
author_facet | Serbecic, Nermin Aboul-Enein, Fahmy Beutelspacher, Sven C. Khan, Adnan Vass, Clemens Kristoferitsch, Wolfgang Reitner, Andreas Schmidt-Erfurth, Ursula |
author_sort | Serbecic, Nermin |
collection | PubMed |
description | Background: Recent studies investigating the use of optical coherence tomography (OCT) in multiple sclerosis (MS) patients have resulted in wide-ranging and often contradictory outcomes. This is mainly due to the complex etiology and heterogeneity of MS, physiological variations in the retinal nerve fiber layer (RNFL) and/or total macular volume (TMV), and limitations in methodology. It remains to be discovered whether any retinal changes in MS develop continuously or in a stepwise fashion, and whether these changes occur in all or a subset of patients. High-resolution spectral domain-OCT devices (SD-OCT) would be required to detect subtle retinal changes and longitudinal studies would have to be carried out to investigate retinal changes over time. In addition, if the hypothesis is correct, then retinal and global brain tissue changes should be detected in a substantial majority of MS patients and detection should be possible with a high degree of disease activity and/or long disease course. Methodology: In order to address the factors above, 37 MS patients (relapsing–remitting, n = 27; secondary progressive, n = 10) were examined prospectively on two occasions with a median interval of 22.4 ± 0.5 months [range 19–27]. SD-OCT was utilized with the Spectralis 3.5 mm circle scan protocol (with locked reference images and eye-tracking mode). None of the patients had optic neuritis 12 months prior to study entry or during the observation period. Principal Findings: The initial TMV pattern differed between study participants, but remained relatively unchanged over the 2-year observation period despite high disease activity or long disease course. The TMV correlated well with the RNFL. Conclusion: The significance of differences in TMV (and RNFL) between study participants remains unclear. Until these differences have been explored further, OCT data in MS patients should be interpreted with caution. |
format | Online Article Text |
id | pubmed-3932446 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-39324462014-03-06 High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II – the Total Macular Volume. The First Follow-Up Study over 2 Years Serbecic, Nermin Aboul-Enein, Fahmy Beutelspacher, Sven C. Khan, Adnan Vass, Clemens Kristoferitsch, Wolfgang Reitner, Andreas Schmidt-Erfurth, Ursula Front Neurol Neuroscience Background: Recent studies investigating the use of optical coherence tomography (OCT) in multiple sclerosis (MS) patients have resulted in wide-ranging and often contradictory outcomes. This is mainly due to the complex etiology and heterogeneity of MS, physiological variations in the retinal nerve fiber layer (RNFL) and/or total macular volume (TMV), and limitations in methodology. It remains to be discovered whether any retinal changes in MS develop continuously or in a stepwise fashion, and whether these changes occur in all or a subset of patients. High-resolution spectral domain-OCT devices (SD-OCT) would be required to detect subtle retinal changes and longitudinal studies would have to be carried out to investigate retinal changes over time. In addition, if the hypothesis is correct, then retinal and global brain tissue changes should be detected in a substantial majority of MS patients and detection should be possible with a high degree of disease activity and/or long disease course. Methodology: In order to address the factors above, 37 MS patients (relapsing–remitting, n = 27; secondary progressive, n = 10) were examined prospectively on two occasions with a median interval of 22.4 ± 0.5 months [range 19–27]. SD-OCT was utilized with the Spectralis 3.5 mm circle scan protocol (with locked reference images and eye-tracking mode). None of the patients had optic neuritis 12 months prior to study entry or during the observation period. Principal Findings: The initial TMV pattern differed between study participants, but remained relatively unchanged over the 2-year observation period despite high disease activity or long disease course. The TMV correlated well with the RNFL. Conclusion: The significance of differences in TMV (and RNFL) between study participants remains unclear. Until these differences have been explored further, OCT data in MS patients should be interpreted with caution. Frontiers Media S.A. 2014-02-24 /pmc/articles/PMC3932446/ /pubmed/24605107 http://dx.doi.org/10.3389/fneur.2014.00020 Text en Copyright © 2014 Serbecic, Aboul-Enein, Beutelspacher, Khan, Vass, Kristoferitsch, Reitner and Schmidt-Erfurth. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Serbecic, Nermin Aboul-Enein, Fahmy Beutelspacher, Sven C. Khan, Adnan Vass, Clemens Kristoferitsch, Wolfgang Reitner, Andreas Schmidt-Erfurth, Ursula High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II – the Total Macular Volume. The First Follow-Up Study over 2 Years |
title | High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II – the Total Macular Volume. The First Follow-Up Study over 2 Years |
title_full | High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II – the Total Macular Volume. The First Follow-Up Study over 2 Years |
title_fullStr | High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II – the Total Macular Volume. The First Follow-Up Study over 2 Years |
title_full_unstemmed | High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II – the Total Macular Volume. The First Follow-Up Study over 2 Years |
title_short | High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II – the Total Macular Volume. The First Follow-Up Study over 2 Years |
title_sort | high-resolution spectral domain-optical coherence tomography in multiple sclerosis, part ii – the total macular volume. the first follow-up study over 2 years |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932446/ https://www.ncbi.nlm.nih.gov/pubmed/24605107 http://dx.doi.org/10.3389/fneur.2014.00020 |
work_keys_str_mv | AT serbecicnermin highresolutionspectraldomainopticalcoherencetomographyinmultiplesclerosispartiithetotalmacularvolumethefirstfollowupstudyover2years AT abouleneinfahmy highresolutionspectraldomainopticalcoherencetomographyinmultiplesclerosispartiithetotalmacularvolumethefirstfollowupstudyover2years AT beutelspachersvenc highresolutionspectraldomainopticalcoherencetomographyinmultiplesclerosispartiithetotalmacularvolumethefirstfollowupstudyover2years AT khanadnan highresolutionspectraldomainopticalcoherencetomographyinmultiplesclerosispartiithetotalmacularvolumethefirstfollowupstudyover2years AT vassclemens highresolutionspectraldomainopticalcoherencetomographyinmultiplesclerosispartiithetotalmacularvolumethefirstfollowupstudyover2years AT kristoferitschwolfgang highresolutionspectraldomainopticalcoherencetomographyinmultiplesclerosispartiithetotalmacularvolumethefirstfollowupstudyover2years AT reitnerandreas highresolutionspectraldomainopticalcoherencetomographyinmultiplesclerosispartiithetotalmacularvolumethefirstfollowupstudyover2years AT schmidterfurthursula highresolutionspectraldomainopticalcoherencetomographyinmultiplesclerosispartiithetotalmacularvolumethefirstfollowupstudyover2years |